Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03959423 · ClinicalTrials.gov registry record · NA
Safety Evaluation of the Advanced Hybrid Closed Loop (AHCL) System
A NA study, sponsored by Medtronic MiniMed.
- Completed
- Registry status
- NA
- Development phase
- 288
- Enrollment target
NCT03959423: Completed NA study, sponsored by Medtronic MiniMed.
NCT03959423 is a NA study that has completed, run by Medtronic MiniMed. The registered enrollment target is 288 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03959423, a NA study, has completed, sponsored by Medtronic MiniMed.
- COMPLETED
- Registry status
- NA
- Development phase
- 288 participants
- Enrollment target
Study Summary
This study is a Safety Evaluation of the Advanced Hybrid Closed Loop (AHCL) System in Type 1 Adult and Pediatric Subjects.
Primary Outcome
The overall mean difference of the change in HbA1c from baseline to end of 3-month Study Period.
Interventions
- DEVICE AHCL insulin pump system
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 288 participants |
| Start Date | 2019-07-24 |
| Est. Completion | 2023-10-27 |
| Phase | NA |
What the finished NCT03959423 record still lists
NCT03959423 is an interventional study that assigns participants to a tested intervention. The registered 288 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower).
The record links to 0 conditions, and to 1 intervention - of which AHCL insulin pump system is the first listed.
NCT03959423 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03959423 about?
NCT03959423 is a clinical study titled "Safety Evaluation of the Advanced Hybrid Closed Loop (AHCL) System". This study is a Safety Evaluation of the Advanced Hybrid Closed Loop (AHCL) System in Type 1 Adult and Pediatric Subjects.
What is the current status of trial NCT03959423?
This trial is currently completed. It is a NA study. The enrollment target is 288 participants. The study started on 2019-07-24. Estimated completion is 2023-10-27.
What interventions are being tested in trial NCT03959423?
The interventions under investigation include: AHCL insulin pump system (DEVICE).
Who is sponsoring clinical trial NCT03959423?
This trial is sponsored by Medtronic MiniMed, which has 29 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03959423's enrollment target sits among peer trials
288 376th of 2000 higher than 1,624 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02098265 · 288 participants · NA
A Closed Loop Neural Activity Triggered Stroke Rehabilitation Device
- NCT03741777 · 288 participants · NA
Comparison of Residual Gastric Volume Between Children Who Drink Different Clear Oral Fluid Volume
- NCT03937635 · 288 participants · Phase 3
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
- NCT04621877 · 288 participants · NA
Lay-Delivered Behavioral Activation in Senior Centers
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI